Clinicopathologic characteristics, co-mutation landscape, and survival outcomes of KRAS-G12D mutant lung adenocarcinoma in comparison to KRAS-G12C and EGFR-mutated subtypes - Abolfathi, Hanie; Kordahi, Manal; Armero, Victoria Saavedra; Gagné, Andréanne; Desmeules, Patrice; Orain, Michèle; Fiset, Pierre Oliver; Boudreau, Dominique K.; Gaudreault, Nathalie; Lamaze, Fabien Claude; Bossé, Yohan; Joubert, Philippe (Lung cancer (Amsterdam, Netherlands), 2025)
Keywords: Adenocarcinoma - genetics; Adenocarcinoma - mortality; Adenocarcinoma - pathology; Adenocarcinoma of Lung - genetics; Adenocarcinoma of Lung - mortality; Adenocarcinoma of Lung - pathology; Adult; Aged; Aged, 80 and over; EGFR; ErbB Receptors - genetics; Female; Humans; KRAS-G12C; KRAS-G12D; Lung adenocarcinoma; Lung Neoplasms - genetics; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Male; Middle Aged; Mutation; Neoplasm Staging; Overall survival; Prognosis; Proto-Oncogene Proteins p21(ras) - genetics; Recurrence-free survival; TNM stage; KRAS-G12C; TNM stage; Lung adenocarcinoma; Recurrence-free survival; Overall survival; EGFR; KRAS-G12D